Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2003
10/29/2003EP1356124A2 Circulating epstein-barr virus dna in the serum of patients with gastric carcinoma
10/29/2003EP1356122A2 Ammonium sulfate for neutralization of inhibitory effects
10/29/2003EP1356120A2 Arrayed polynucleotides and their use in genome analysis
10/29/2003EP1356119A2 The preparation of polynucleotide arrays
10/29/2003EP1356118A2 Method for non-redundant library construction
10/29/2003EP1356117A2 Polynucleotides for use as tags and tag complements, manufacture and use thereof
10/29/2003EP1356116A2 Hybridization buffers using low molecular weight dextran sulfate and methods for their use
10/29/2003EP1356112A2 Methods for assessing the risk of non-insulin-dependent diabetes mellitus based on allelic variations in the 5'-flanking region of the insulin gene and body fat
10/29/2003EP1356111A2 Nucleus export reporter system
10/29/2003EP1356110A2 Non-invasive method for detecting target rna
10/29/2003EP1356108A2 Expression analysis of fkbp nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
10/29/2003EP1356107A2 Expression analysis of inhibitor of differentiation nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
10/29/2003EP1356105A2 Method for identifying compounds or lead structures against rna target motifs and rna/protein interactions
10/29/2003EP1356104A2 Methods and probes for detection and/or quantification of nucleic acid sequences
10/29/2003EP1356103A2 Compositions, methods and kits for determining the presence of cryptosporidium organisms in a test sample
10/29/2003EP1356102A2 Polymorphic sequences of the human abca1 gene, their uses, detection methods and kits
10/29/2003EP1356099A2 Method and nucleic acids for the analysis of astrocytomas
10/29/2003EP1356097A2 The anti-neoplastic agent et-743 inhibits trans activation by sxr
10/29/2003EP1356095A2 Method for identifying metastatic tumor cells
10/29/2003EP1356094A2 Methods and compositions for transcription-based nucleic acid amplification
10/29/2003EP1356093A2 Gene markers for lung cancer
10/29/2003EP1356092A2 Compositions and methods for the therapy and diagnosis of ovarian cancer
10/29/2003EP1356091A2 Method of detecting inflammatory lung disorders
10/29/2003EP1356090A2 Sequence based screening
10/29/2003EP1356088A2 Compositions and methods for array-based nucleic acid hybridization
10/29/2003EP1356086A2 Method for the simultaneous dissection in specific positions of filiform organic molecular chains, in particular dna
10/29/2003EP1356085A2 Identification of modulators of dham-kinase and inflammatory diseases
10/29/2003EP1356084A2 Homo-doubly labeled compositions for the detection of enzyme activity in biological samples
10/29/2003EP1356081A2 Method and device for detecting bacterial contamination
10/29/2003EP1356079A2 Srebp pathway modulation through targeting hisrs
10/29/2003EP1356076A1 Methods and compositions for extracting proteins from cells
10/29/2003EP1356075A2 Protein scaffolds for antibody mimics and other binding proteins
10/29/2003EP1356073A2 Fermentation method for production of heterologous gene products in lactic acid bacteria
10/29/2003EP1356072A2 Compositions and methods for the synthesis and subsequent modification of uridine-5'-diphosphosulfoquinovose (udp-sq)
10/29/2003EP1356071A2 Genetically engineered herpes virus for the treatment of cardiovascular disease
10/29/2003EP1356070A2 Conditionally replicating viral vectors and their use
10/29/2003EP1356069A2 Enhanced transfection system
10/29/2003EP1356068A2 Method for secretory production of glycoprotein having human-type sugar chain using plant cell
10/29/2003EP1356066A2 Control of gene expression in plants
10/29/2003EP1356065A2 Method of imparting disease resistance to plants by reducing polyphenol oxidase activity
10/29/2003EP1356064A2 Transcriptional regulator nucleic acids, polypeptides and methods of use thereof
10/29/2003EP1356063A1 Expression of multiple proteins in transgenic plants
10/29/2003EP1356062A2 Generation of human cytomegalovirus yeast artificial chromosome recombinants
10/29/2003EP1356061A2 Artificial transcriptional factors and methods of use
10/29/2003EP1356060A2 Twin-arginine translocation in bacillus
10/29/2003EP1356059A1 Human lipase and polynucleotides encoding the same
10/29/2003EP1356058A2 Crystal structure of dimethylarginine dimethylaminohydrolase and arginine deiminase
10/29/2003EP1356056A2 Method for the expression of biosynthetic genes in plant seeds using novel multiple expression constructs
10/29/2003EP1356055A2 Plant acyl-coa synthetases
10/29/2003EP1356054A2 Bacillus thuringiensis proteins and vatiants thereof with pesticidal activity against coleopterans
10/29/2003EP1356053A2 Histone deacetylase inhibitors in diagnosis and treatment of thyroid neoplasms
10/29/2003EP1356052A2 Prokaryotically produced antibodies and uses thereof
10/29/2003EP1356051A2 Genes
10/29/2003EP1356050A2 Fluorescent proteins
10/29/2003EP1356049A2 Human sugar transporter proteins, potassium channel proteins, phospholipid transporter proteins and methods of use thereof
10/29/2003EP1356048A2 Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
10/29/2003EP1356047A2 Human proteins, polynucleotides encoding them and methods of using the same
10/29/2003EP1356046A2 Cytokine receptor zcytor19
10/29/2003EP1356045A2 Egf motif protein, egfl6 materials and methods
10/29/2003EP1356044A2 32146 and 57259, novel human transporters and uses thereof
10/29/2003EP1356043A2 Novel proteins and nucleic acids encoding same and antibodies directed against these proteins
10/29/2003EP1356042A2 Carbohydrate-associated proteins
10/29/2003EP1356041A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/29/2003EP1356040A2 14189, a novel human kinase and uses thereof
10/29/2003EP1356039A2 Down syndrome critical region 1-like 1 proteins
10/29/2003EP1356038A2 Compositions and methods relating to lung specific genes and proteins
10/29/2003EP1356037A2 A library of a collection of cells
10/29/2003EP1356036A2 Process and compositions for peptide, protein and peptidomimetic synthesis
10/29/2003EP1356035A1 Methods for cloning mammals using reprogrammed donor chromatin or donor cells
10/29/2003EP1356034A2 Genes associated with allergic hypersensitivity and mast cell activation
10/29/2003EP1356033A2 Methyl-d-erythritol phosphate pathway genes
10/29/2003EP1356032A2 Human kinases
10/29/2003EP1356031A2 Effective nuclear reprogramming in mammals
10/29/2003EP1356030A1 Runx3 gene showing anti-tumor activity and use thereof
10/29/2003EP1356028A2 Protein modification and maintenance molecules
10/29/2003EP1356026A2 Micromonospora echinospora genes encoding for biosynthesis of calicheamicin and self-resistance thereto
10/29/2003EP1356025A1 Mammalian cancer cell and transgenic mammal carrying human protooncogene and kit for diagnosing cancer using said protooncogene
10/29/2003EP1356023A2 Isolation of binding proteins with high affinity to ligands
10/29/2003EP1355950A1 Antibodies for human cytochrome p450 2d6
10/29/2003EP1355949A1 Conformationally abnormal forms of tau proteins and specific antibodies thereto
10/29/2003EP1355947A2 Monoclonal antibodies specific for the e2 glycoprotein of hepatitis c virus and their use in the diagnosis, treatment, and prevention of hepatitis c
10/29/2003EP1355945A2 Flint glycoforms
10/29/2003EP1355943A2 Neurotransmitter transporters
10/29/2003EP1355942A2 Glp-1 fusion proteins
10/29/2003EP1355939A2 Interferons, uses and compositions related thereto
10/29/2003EP1355937A2 Mammalian alpha-helical protein-53
10/29/2003EP1355936A2 Polymer conjugates of neublastin and methods of using same
10/29/2003EP1355935A2 Secreted proteins
10/29/2003EP1355934A2 Compositions and methods relating to lung specific genes and proteins
10/29/2003EP1355933A2 Iron regulating protein-2 (irp-2) as a diagnostic for neurodegenerative diseases
10/29/2003EP1355932A2 Method and nucleic acids for the differentiation of astrocytoma, oligoastrocytoma and oligodendroglioma tumor cells
10/29/2003EP1355930A2 A method for identification, isolation and production of antigens to a specific pathogen
10/29/2003EP1355929A2 Basb209 polypeptides and polynucleotides from haemophilus influenzae
10/29/2003EP1355928A1 Universal carrier for targeting molecules to gb3 receptor expressing cells
10/29/2003EP1355927A2 Identification of the anti-sigma-28 factor in helicobacter pylori, in campylobacter jejuni and in pseudomonas aeruginosa and application thereof
10/29/2003EP1355926A2 Therapeutic compounds for ovarian cancer
10/29/2003EP1355924A2 Armed peptides
10/29/2003EP1355923A2 Immunomodulatory peptides derived from heat shock proteins and uses thereof
10/29/2003EP1355922A2 Stress proteins and peptides and methods of use thereof
10/29/2003EP1355921A2 Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof
1 ... 2389 2390 2391 2392 2393 2394 2395 2396 2397 2398 2399 2400 2401 2402 2403 2404 2405 2406 2407 2408 2409 ... 4023